About Elixir Pharma
Elixir Pharma is a Healthcare company based in Ahmedabad (India). Elixir Pharma is engaged in manufacturing pharmaceutical APIs globally. It operates on a Reseller / Distribution and B2B2C model. Elixir Pharma offers products and services including API Commercial, API Under Development, and Intermediates. Its focus areas include Pharmaceuticals and Active Pharmaceutical Ingredients. Its legal entity in India is Elixir Pharma Pvt. Ltd (U52399GJ2010PTC060831). Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
Elixir Pharma is involved in the production of Active Pharmaceutical Ingredients (APIs) and intermediates for the global pharmaceutical industry. Based in Ahmedabad, India, the company is committed to quality and compliance with international standards such as ISO 9001, 14001, 18001, and WHO GMP. Solutions are provided to life science companies through innovative research, just-in-time manufacturing, and strong after-sales support. Operations are conducted with a focus on environmental sustainability and safety, serving markets in regions like Russia, USA, and Asia.
- Headquarters Ahmedabad, India
- SectorsHealthcare
- Phone•••• ••••
- Website elixirpharma.in
- Social X
- Legal Name Elixir Pharma Pvt. Ltd.
- Date of Incorporation 20 May, 2010
- Jurisdiction Ahmedabad, Gujarat, India
- Net Loss-₹55,649
FY 2022 · 0% margin
- EBITDA-₹55,649
FY 2022 · 0% margin
Associated legal entities of Elixir Pharma
Elixir Pharma operates through Nxtwork Trades Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nxtwork Trades Private Limited CIN U52399GJ2010PTC060831 | Active | 20 May 2010 | Ahmedabad, Gujarat | – | – | 3 | View details |
Products & Services of Elixir Pharma
Elixir Pharma offers a comprehensive portfolio of products and services, including API Commercial, API Under Development, and Intermediates.
Commercial APIs are produced with high quality standards.
Novel APIs are developed for future therapeutic use.
Intermediates are provided for complex API synthesis needs.
Board of directors of Nxtwork Trades Private Limited (Elixir Pharma)
Nxtwork Trades Private Limited is the primary company behind Elixir Pharma. The board of Nxtwork Trades Private Limited currently have 3 directors; the longest-serving is Jayesh Ramanbhai Patel, appointed in 2010. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jayesh Ramanbhai Patel DIN 03052841 | Director | 20 May 2010 | 16 yrs 5 mo | Nxtwork Trades Private Limited |
| Jignesh Patel Baldevbhai DIN 07017235 | Director | 13 Nov 2014 | 11 yrs 11 mo | Nxtwork Trades Private Limited |
| Rameshbhai Bababhai Prajapati DIN 00753711 | Director | 10 Aug 2015 | 11 yrs 2 mo | Nxtwork Trades Private Limited |
Financials of Elixir Pharma
Figures of Nxtwork Trades Private Limited, the primary company behind Elixir Pharma, for FY 2022. Net loss was -₹55,649 (0% margin). EBITDA was -₹55,649 (0% margin). Revenue has grown at a compounded annual rate of -100% over five years.
- -₹55,649Net loss · 0% margin
- -₹55,649EBITDA · 0% margin
- ₹1 LakhPaid-up capital
- -100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nxtwork Trades Private Limited are on its company page.
Detailed financial statements for Elixir Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Elixir Pharma
Elixir Pharma has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of Elixir Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Elixir Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Elixir Pharma
Complete news archive for Elixir Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elixir Pharma
Elixir Pharma is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Elixir Pharma is involved in the production of Active Pharmaceutical Ingredients (APIs) and intermediates for the global pharmaceutical industry. Based in Ahmedabad, India, the company is committed to quality and compliance with international standards such as ISO 9001, 14001, 18001, and WHO GMP. Solutions are provided to life science companies through innovative research, just-in-time manufacturing, and strong after-sales support. Operations are conducted with a focus on environmental sustainability and safety, serving markets in regions like Russia, USA, and Asia.
Elixir Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Elixir Pharma offers API Commercial, API Under Development, and Intermediates.
Elixir Pharma operates through Nxtwork Trades Private Limited.
The legal entities of Elixir Pharma currently have 3 directors, including Rameshbhai Bababhai Prajapati, Jayesh Ramanbhai Patel, Jignesh Patel Baldevbhai.